Daiichi Sankyo shares rose sharply after the Japanese drugmaker announced a multibillion dollar deal with Merck to jointly develop and commercialize three cancer drug candidates.
You are here: Home / Top Stories / Dow Jones Newswires: Daiichi Sankyo shares jump on multibillion-dollar drug development deal with Merck